Valter Torri

ScholarGPS® ID: 50811688126996

Affiliation

Istituto di Ricovero e Cura a Carattere Scientifico, Italy

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

316

Predicted Citations

20,092

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
25P PROgnostic Signature in stage II colon cancer (CC) patients enrolled in the phase III clinical trial TOSCA: PROSIT study (journal article) Puccini, A. \| Ferrando, L. \| Mazzarella, L. \| Frige, G. \| Pessino, A. \| Pastorino, A. \| Martelli, V. \| Garuti, A. \| Ballestrero, A. \| Torri, V. \| ... \| Sobrero, A. Annals of Oncology, volume 35 (2024). 10.1016/j.annonc.2024.05.036 Cite \| Source
Highly prognostic signature for stage II colon cancer from the TOSCA trial: The PROSIT study. (journal article) Puccini, Alberto \| Ferrando, Lorenzo \| Mazzarella, Luca \| Frige, Gianmaria \| Pessino, Anna Maria \| Pastorino, Alessandro \| Martelli, Valentino \| Garuti, Anna \| Di Antonio, Veronica \| Ballestrero, Alberto \| ... \| Sobrero, Alberto F. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 3524-3524 (2024). 10.1200/JCO.2024.42.16_suppl.3524 Cite \| Source
Neoadjuvant or Perioperative Approach in Lung Cancer (journal article) Garassino, Marina Chiara \| Torri, Valter New England Journal of Medicine, volume 390, issue 19, pages 1816-1818 (2024). 10.1056/NEJMe2403723 Cited by (1) \| Cite \| Source
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis (journal article) Nader-Marta, G. \| Monteforte, M. \| Agostinetto, E. \| Cinquini, M. \| Martins-Branco, D. \| Langouo, M. \| Llombart-Cusac, A. \| Cortés, J. \| Ignatiadis, M. \| Torri, V. \| ... \| Di Cosimo, S. ESMO Open, volume 9, issue 3, pages 102390- (2024). 10.1016/j.esmoop.2024.102390 Cited by (4) \| Cite \| Source
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC (journal article) Hines, Jacobi B. \| Cameron, Robert B. \| Esposito, Alessandra \| Kim, Leeseul \| Porcu, Luca \| Nuccio, Antonio \| Viscardi, Giuseppe \| Ferrara, Roberto \| Veronesi, Giulia \| Forde, Patrick M. \| ... \| Torri, Valter Journal of Thoracic Oncology (2024). 10.1016/j.jtho.2024.03.010 Cited by (7) \| Cite \| Source
P1.25-02 Complete Pathologic Response (pCR) as a Surrogate Endpoint in Neoadjuvant Immunotherapy Clinical Trials for NSCLC: A Meta-analysis (journal article) Hines, J. \| Cameron, R. \| Torri, V. \| Cascone, T. \| Forde, P.M. \| Esposito, A. \| Vokes, E. \| Bestvina, C. \| Marina, G.C. \| Porcu, L. Journal of Thoracic Oncology, volume 18, issue 11, pages S268- (2023). 10.1016/j.jtho.2023.09.456 Cite \| Source
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study (journal article) Bogani, Giorgio \| Cinquini, Michela \| Signorelli, Diego \| Pizzutilo, Elio G. \| Romanò, Rebecca \| Bersanelli, Melissa \| Raggi, Daniele \| Alfieri, Salvatore \| Buti, Sebastiano \| Bertolini, Federica \| ... \| Giannatempo, Patrizia Critical Reviews in Oncology/Hematology, volume 187 (2023). 10.1016/j.critrevonc.2023.104016 Cited by (9) \| Cite \| Source
First line combination of ribociclib and letrozole in patients (pts) with metastatic breast cancer (MBC): Focus on hepatic toxicity in the context of a real–world setting the Italian, multicenter Hermione–8 study. (journal article) Piazza, Francesca \| Bonelli, Candida \| Lui, Stefania \| di Nunzio, Camilla \| Collova, Elena \| Bozzoli, Elisabetta \| Vici, Patrizia \| Gebbia, Vittorio \| Valerio, Maria Rosaria \| Zustovich, Fable \| ... \| Cazzaniga, Marina Elena Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e13064-e13064 (2023). 10.1200/JCO.2023.41.16_suppl.e13064 Cited by (1) \| Cite \| Source
26P ctDNA prognostic and diagnostic value for recurrence in patients with early-stage breast cancer: A systematic review and meta-analysis (journal article) Marta, G. Nader \| Monforte, M. \| Cinquini, M. \| Agostinetto, E. \| Branco, D. Martins \| Fontsa, M. Langouo \| Ignatiadis, M. \| Torri, V. \| Apolone, G. \| Cappelletti, V. \| ... \| Di Cosimo, S. ESMO Open, volume 8, issue 1, pages 101250- (2023). 10.1016/j.esmoop.2023.101250 Cite \| Source
MO-0139 Mepitel Film vs standard treatment for preventing radiotherapy skin toxicity: phase III study (journal article) Valli, M. \| Valcarenghi, D. \| Tolotti, A. \| Vees, H. \| Liptrott, S. \| Puliatti, A. \| Presta, G. \| Torri, V. \| Moser, L Radiotherapy and Oncology, volume 182 (2023). 10.1016/S0167-8140(23)08330-5 Cite \| Source
PP01.01 PEOPLE (NTC03447678), a Phase II Trial to Test Biomarkers of Response to Pembrolizumab as First-Line Treatment in Advanced NSCLC Patients with PD-L1>50% (journal article) Dolezal, J. \| Lo Russo, G. \| Proto, C. \| Prelaj, A. \| Ganzinelli, M. \| Mortarini, R. \| Torri, V. \| Ferarra, R. \| Agnelli, L. \| Brich, S. \| Garassino, M.C. Journal of Thoracic Oncology, volume 18, issue 3, pages e10- (2023). 10.1016/j.jtho.2022.09.027 Cite \| Source
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform (journal article) Scorsetti, Marta \| Navarria, Pierina \| Cozzi, Luca \| Clerici, Elena \| Bellu, Luisa \| Franceschini, Davide \| Marzo, Antonio Marco \| Franzese, Ciro \| Torri, Valter \| Reggiori, Giacomo \| ... \| Tomatis, Stefano Radiation Oncology, volume 18, issue 1 (2023). 10.1186/s13014-023-02216-5 Cited by (9) \| Cite \| Source
Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancer (journal article) Nicoletto, Maria Ornella \| Baldoni, Alessandra \| Cavallin, Francesco \| Grego, Andrea \| Falci, Cristina \| Nardin, Margherita \| Mammano, Enzo \| Lai, Eleonora \| Torri, Valter Therapeutic Advances in Medical Oncology, volume 15 (2023). 10.1177/17588359231173181 Cite \| Source
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer? (journal article) Cameron, Robert B. \| Hines, Jacobi B. \| Torri, Valter \| Porcu, Luca \| Donington, Jessica \| Bestvina, Christine M. \| Vokes, Everett \| Dolezal, James M. \| Esposito, Alessandra \| Garassino, Marina C. Therapeutic Advances in Medical Oncology, volume 15 (2023). 10.1177/17588359231198446 Cite \| Source
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)—a collaborative randomized controlled trial (journal article) Di Giorgio, A. \| Gerardi, C. \| Abatini, C. \| Melotti, G. \| Bonavina, L. \| Torri, V. \| Santullo, F. \| Garattini, S. \| De Luca, M. \| Rulli, Erica \| ... \| Pacelli, F. Trials, volume 23, issue 1 (2022). 10.1186/s13063-022-06880-y Cited by (3) \| Cite \| Source
Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study (journal article) Navarria, Pierina \| Baldaccini, Davide \| Clerici, Elena \| Marini, Beatrice \| Cozzi, Luca \| Franceschini, Davide \| Bertuzzi, Alexia Francesca \| Quagliuolo, Vittorio \| Torri, Valter \| Colombo, Piergiuseppe \| ... \| Scorsetti, Marta International Journal of Radiation OncologyBiologyPhysics, volume 114, issue 4, pages 762-770 (2022). 10.1016/j.ijrobp.2022.08.028 Cited by (15) \| Cite \| Source
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study – protocol for a randomised, (journal article) Pacelli, Fabio \| Gerardi, Chiara \| Rulli, Eliana \| Abatini, Carlo \| Rotolo, Stefano \| Garattini, Silvio \| Melotti, Gianluigi \| Torri, Valter \| Galli, Fabio \| Rulli, Erica \| Di Giorgio, Andrea BMJ Open, volume 12, issue 8, pages e051324- (2022). 10.1136/bmjopen-2021-051324 Cited by (2) \| Cite \| Source
Bevacizumab for advanced ovarian cancer treatment. A GRADE based approach (journal article) Pappagallo, Giovanni L. \| Torri, Valter Epidemiology, Biostatistics, and Public Health, volume 10, issue 1 (2022). 10.2427/8826 Cite \| Source
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer (journal article) Cavalleri, Tommaso \| Greco, Luana \| Rubbino, Federica \| Hamada, Tsuyoshi \| Quaranta, Maria \| Grizzi, Fabio \| Sauta, Elisabetta \| Craviotto, Vincenzo \| Bossi, Paola \| Vetrano, Stefania \| ... \| Laghi, Luigi The Journal of Pathology: Clinical Research, volume 8, issue 4, pages 307-312 (2022). 10.1002/cjp2.267 Cited by (9) \| Cite \| Source
Phase III study to compare bevacizumab or cetuximab plus FOLFIRI in patients with advanced colorectal cancer RAS/BRAF wild type (wt) on tumor tissue and RAS mutated (mut) in liquid biopsy: LIBImAb Study. (journal article) Damato, Angela \| Damato, Angela \| Aschele, Carlo \| Ciardiello, Fortunato \| Maiello, Evaristo \| Siena, Salvatore \| Torri, Valter \| Dolcini, Virginia \| Gervasi, Erika \| La Grotteria, Ilenia \| ... \| Normanno, Nicola Journal of Clinical Oncology, volume 40, issue 16_suppl, pages TPS3636-TPS3636 (2022). 10.1200/JCO.2022.40.16_suppl.TPS3636 Cite \| Source